Arkolith/Insider Trading/ACRX/Form 4

Dasu Badri N

Chief Engineering OfficerACELRX PHARMACEUTICALS INC (ACRX) · full profile →Form 4 · filed Feb 14, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2022Grant(A)98K—$0302K
Feb 11, 2022Tax withholding(F)6K$0.40$2K296K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2022Grant(A)195K—$0195K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-009349) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML